Last reviewed · How we verify
X-22 Smoking Cessation Product — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
X-22 Smoking Cessation Product (X-22 Smoking Cessation Product) — 22nd Century Limited, LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| X-22 Smoking Cessation Product TARGET | X-22 Smoking Cessation Product | 22nd Century Limited, LLC | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- X-22 Smoking Cessation Product CI watch — RSS
- X-22 Smoking Cessation Product CI watch — Atom
- X-22 Smoking Cessation Product CI watch — JSON
- X-22 Smoking Cessation Product alone — RSS
Cite this brief
Drug Landscape (2026). X-22 Smoking Cessation Product — Competitive Intelligence Brief. https://druglandscape.com/ci/x-22-smoking-cessation-product. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab